Department of Health and Human Services June 25, 2018 – Federal Register Recent Federal Regulation Documents

Agency Forms Undergoing Paperwork Reduction Act Review
Document Number: 2018-13544
Type: Notice
Date: 2018-06-25
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Agency Forms Undergoing Paperwork Reduction Act Review
Document Number: 2018-13543
Type: Notice
Date: 2018-06-25
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Medicare Program; Request for Information Regarding the Physician Self-Referral Law
Document Number: 2018-13529
Type: Proposed Rule
Date: 2018-06-25
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
This request for information seeks input from the public on how to address any undue regulatory impact and burden of the physician self-referral law.
Notice; Children's Bureau Proposed Research Priorities for Fiscal Years 2018-2020
Document Number: 2018-13526
Type: Notice
Date: 2018-06-25
Agency: Department of Health and Human Services, Administration for Children and Families
The Children's Bureau (CB) within the Administration on Children, Youth and Families (ACYF) announces the proposed priorities for research on the causes, prevention, assessment, identification, treatment, cultural and socio-economic distinctions, and the consequences of child abuse and neglect, and solicits comments regarding the prioritization.
Prospective Grant of Exclusive Patent License: Mutant IDH1 Inhibitors Useful for Treating Cancer
Document Number: 2018-13486
Type: Notice
Date: 2018-06-25
Agency: Department of Health and Human Services, National Institutes of Health
National Center for Advancing Translational Sciences, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in the Patent Applications listed in the Summary Information section of this notice to Apexx Oncology, Inc., located in New York, NY.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.